Invested in
Sotera Health?
Attention Sotera Health shareholders: contact investor lawyers for a free evaluation of your potential claims for compensation today.
- Did you acquire shares of Sotera Health Co (Nasdaq: SHC) in or about November 2020, and do you still hold your SHC shares?
- Are you concerned about the performance of SHC stock since it became publicly listed?
- Are you concerned about the conduct of Sotera Health’s officers and directors, following allegations of materially false and misleading statements concerning its emissions control systems and exposure to liability from lawsuits due the Sotera’s alleged failure to limit harmful Ethylene Oxide (“EtO”) emissions?
- Would you like your potential options for compensation and/or redress to be reviewed by an experienced team of investor lawyers?
Request a free case evaluation of your potential claims for compensation today, via email at arosca@rscounsel.law, through the contact form on this page, or by calling 888-998-0530.
Contact Us About Your
Investments
Free Case Evaluation
The Sotera Health Class Action Investigation page is the resource for long term shareholders who bought Sotera Health shares in November 2020 and would like to evaluate compensation claims.
- Free Case Evaluation
- No Fees if No Recovery
- Contact Us Today
We can also do a Zoom call to discuss your matter.
Posted September 22, 2023
Sotera Health Investigation
Securities attorneys Alan Rosca, Paul Scarlato, and Kathryn Weidner have been investigating alleged securities violations, corporate misconduct, and misrepresentations, as well as questionable business practices involving Sotera Health Co, and have identified potential areas of concern for Sotera Health investors.
What Sotera Health Investors May Do
SHC investors interested in an evaluation of their potential options to seek compensation and/or pursue claims related to their Sotera Health investment may contact investor rights attorneys Alan Rosca, Paul Scarlato, or Kathryn Weidner. Claims that are not timely pursued may expire or otherwise be lost, generally speaking.
Get in Touch with an Experienced Team of Investor Attorneys
Attorneys Rosca, Scarlato, and Weidner have extensive experience in seeking compensation related to investor harm and pursuing claims arising out of alleged violations of securities law and/or corporate misconduct, and are currently evaluating potential claims on behalf of investors in Sotera Health Co.
They typically work on a contingent fee basis, do not require any money down from their clients, advance case expenses, and only get paid for their fees and expenses if and when successful, following review and approval by the Court of any fee application.
Concerned SHC stock investors may contact attorneys Alan Rosca, Paul Scarlato, or Kathryn Weidner to discuss their potential options toll free at 888-998-0530, via email at arosca@rscounsel.law, or through the contact form on this webpage.
Potential Compensation Claims
Has Sotera Health’s Management Been Accused of Misconduct?
Sotera Health, and certain of its senior officers and directors, have been subject to a class action lawsuit, filed in the United States District Court for the Northen District of Ohio in January 2023.
Sotera Health and its control persons were accused in that class action lawsuit of, among others, violating securities laws by allegedly making materially false and/or misleading statements and failing to disclose materially adverse facts that allegedly caused Sotera Health’s stock to trade at artificially inflated prices.
According to the complaint, Sotera Health allegedly failed to inform investors that for years the Company failed to prevent the release of excessive amounts of toxic EtO gas from its sterilization facilities by allegedly failing to employ effective emissions control systems.
Despite allegedly being aware of the contrary, Sotera’s executives denied allegations that Sotera’s EtO emissions cause severe health issues, including cancer, in people living in communities surrounding its sterilization facilities, while assuring investors that the company’s safeguards to control EtO emissions were adequate and effective, according to the complaint.
What Happened to SHC Stock Price in September 2022?
SHC shareholders allegedly became aware of Sotera Health’s misrepresentations in connection with its EtO emissions in September 2022, when a jury in Illinois found Sotera liable for the plaintiff’s cancer, awarding the plaintiff $38 million in compensatory damages and $325 million in punitive damages (Kamuda v. Sterigenics U.S., LLC, No. 18 L 10475 (Ill. Cir. Ct.). The jury reportedly cited Sotera’s failure to warn about the alleged health hazard, and its “willful and wanton” misconduct in not preventing toxic EtO emissions, according to the class action complaint. Following the news, Sotera’s stock price reportedly declined over $4 per share, to $9.83 on September 19, 2022, the complaint adds.
Furthermore, on the same day, media reports revealed that corporate documents and internal correspondence indicated Sotera “knew long ago” but intentionally delayed installing pollution-control equipment, the class action complaint alleges.
On September 20, 2022, analysts at Goldman Sachs reportedly downgraded Sotera stock due to significant risk of future litigation, which was followed by additional decline of price per SHC share to $8.20, according to the complaint. The price reportedly fell to $7.32 on the next day, after JP Morgan also downgraded Sotera.
Data from Yahoo Finance indicates that as of the date of this article, the price per SHC share recovered since the September 2022 drop, but at $15.36 per share it still trades almost 39% lower compared to its closing price on the day of its IPO.
Potential Compensation Claims
Potential Claims for Compensation for Sotera Health Shareholders
Investor rights attorneys Alan Rosca, Paul Scarlato, and Kathryn Weidner at Rosca Scarlato are investigating potential options and are evaluating potential claims for compensation on behalf of SHC shareholders who have held SHC shares since November 2020. They have decades of combined experience representing victims of corporate or financial misconduct.
If you are a Sotera Health investor concerned about your investment and/or its value and have purchased your Sotera Health shares in November 2020, you may contact attorneys Alan Rosca, Paul Scarlato, or Kathryn Weidner to learn more about your rights and for an evaluation of your potential claims, or to provide useful information.
All consultations are free. The Rosca Scarlato attorneys typically take cases like this on a contingency fee basis, advance all case costs, and only get paid for their fees and expenses if and when they are successful, following review and approval by the Court of any fee application.
To reach attorney Alan Rosca or his colleagues, Sotera Health investors may call 888-998-0530, email arosca@rscounsel.law, or leave a message through the contact form on this webpage.
The general considerations on this page are for informational purposes only and do not constitute legal advice. Such legal advice can only be offered once the attorneys discuss each investor’s situation, learn of the relevant facts and can tailor any advice to that investor’s facts. The Sotera Health Class Action Investigation page is not affiliated with Sotera Health Co. There has not been an adjudication on the merits of any allegations referenced in this blog post, as of the date of the posting.
Contact info:
Rosca Scarlato LLC – 216-946-7070 / 888-998-0530.
Alan Rosca – arosca@rscounsel.law
Paul Scarlato – pscarlato@rscounsel.law
Kathryn Weidner – kweidner@rscounsel.law
Recent Investigations
DISCLAIMER
In our legal system, every person is innocent until and unless found guilty by a court of law or a tribunal. Whenever we reference “allegations” or charges that are “alleged,” such allegations or charges have not been proven, and are merely accusations, not findings of fault, as of the date of the blog. We do not have, nor do we undertake, a duty to continue to monitor or follow matters about which we report, and/or to publish subsequent updates regarding various developments that may occur in such matters. Readers are encouraged to conduct their own research regarding any such matters and any developments that may or may not have occurred in such matters. Also, the Brokercheck report linked to some of our blogs is the up-to-date version as of the date of accessing by the reader. The information in our blogs is current as of the date of the drafting of the blog, and given that sometimes certain past complaints may no longer be listed in newer Brokercheck reports, some of the events referenced in some of our blogs may later on be removed from newer Brokercheck reports. Visitors may check the most recent version of each brokercheck report at www.finra.org, and may contact FINRA for the earlier version of the Brokercheck report upon which various blogs may be based.
